Software that analyzes snippets of your speech to identify mental health problems is rapidly making its way into call centers, medical clinics and telehealth platforms. The idea is to detect illnesses that might otherwise go untreated. Why it matters: Proponents of "voice biomarker" technology say the underlying artificial intelligence is good enough to recognize depression, anxiety and a host of other maladies.
Read MoreBOSTON--(BUSINESS WIRE)--Sonde Health and the Cognitive Behavior Institute (CBI) have teamed up to study the effectiveness of Sonde’s Mental Fitness app as an engagement and monitoring tool for patients with depression and anxiety to help health systems and wellness service providers enhance patient care.
The study will use Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that analyzes the sound of patients’ voices to evaluate aspects of mental well-being. By combining voice recordings, patient symptoms, and medical data, this research will enable Sonde to continue to improve its vocal biomarker models for depression and mental health monitoring.
A leader from the health tech company explains how voice-based technologies could transform monitoring of patients with dementia, Alzheimer's, and other conditions.
Vocal biomarkers can be highly useful, telling caregivers and researchers things that other vital signs are not able to fully show. Outsourcing-Pharma recently spoke with David Liu, CEO of health technology company Sonde Health, about the potential of vocal biomarkers in research and care, and how the company's voice-enabled symptom detection and monitoring platform can be useful in watching chronic and mental health conditions
Imagine a test as quick and easy as having your temperature taken or your blood pressure measured that could reliably identify an anxiety disorder or predict an impending depressive relapse.
Health care providers have many tools to gauge a patient’s physical condition, yet no reliable biomarkers — objective indicators of medical states observed from outside the patient — for assessing mental health.
But some artificial intelligence researchers now believe that the sound of your voice might be the key to understanding your mental state — and A.I. is perfectly suited to detect such changes, which are difficult, if not impossible, to perceive otherwise. The result is a set of apps and online tools designed to track your mental status, as well as programs that deliver real-time mental health assessments to telehealth and call-center providers.
Read MoreBOSTON--(BUSINESS WIRE)--Sonde Health announced that it will work with leading chipmaker Qualcomm Technologies, Inc. to optimize Sonde’s vocal biomarker technology for use with the flagship and high-tier Qualcomm® Snapdragon™ 888 and 778G 5G Mobile Platforms to help bring native, machine learning-driven vocal biomarker capabilities to mobile and IoT devices globally. The optimization has the potential to unlock several native health screening and monitoring applications on hundreds of millions of mobile devices that use these Snapdragon mobile platforms.
Read MoreQualcomm has finally unveiled the new Snapdragon 8 Gen 1 mobile platform, the first chipset to adopt Qualcomm's new naming convention that it teased earlier this month. This new "simplified" naming scheme represents a new generation for Qualcomm that focuses its efforts on advanced AI processing and fast 5G speeds.
Read MoreDuring the annual Snapdragon Tech Summit 2021, Qualcomm Technologies, Inc. introduced its latest premium 5G mobile platform, Snapdragon® 8 Gen 1. The new Snapdragon 8 leads the way into a new era of premium mobile technology equipped with cutting-edge 5G, AI, gaming, camera, and Wi-Fi and Bluetooth® technologies to transform the next generation of flagship devices. Snapdragon 8 Gen 1 will be adopted by global OEMs and brands including Black Shark, Honor, iQOO, Motorola, Nubia, OnePlus, OPPO, Realme, Redmi, SHARP, Sony Corporation, vivo, Xiaomi, and ZTE, with commercial devices expected by the end of 2021.
Read MoreVocal biomarker startup Sonde has been quietly plotting a way to make tracking respiratory and mental health as simple as chatting to a smartphone voice assistant.
The Boston-based company, which was founded in 2015, has raised $19 million for its technology that uses brief voice recordings to reveal the progression of health conditions. On Thursday, Sonde announced a new partnership with chip manufacturing giant Qualcomm that could potentially bring the technology to millions of smartphones, which could prove a crucial test of whether its tech is ready for prime time.
Read More